Literature DB >> 23373017

The anti mullerian hormone- a novel marker for assessing the ovarian reserve in women with regular menstrual cycles.

V S Kalaiselvi1, Saikumar P, Prabhu K, Prashanth Krishna G.   

Abstract

BACKGROUND: Ovarian Reserve (OR) is a term which describes the functional potential of the ovary, which constitutes the size of the ovarian follicle pool and reflects the number and quality of the oocytes which are within it. Assessment of the OR helps in reflecting the reproductive potential of women. Various markers are available for assessing the OR and the best marker is the Anti Mullerian Hormone (AMH) which reflects the ovarian follicular pool in the ovary. In this study, the serum level of AMH/MIS(Mullerian Inhibiting Substance)was estimated to assess the ovarian reserve in both fertile and infertile women.
OBJECTIVE: To assess the ovarian reserve in women of the fertile and subfertile groups with regular cycles, who were in the age range of 26 -33yrs, by estimating the level of AMH and those of other hormones like FSH and E2 and also to calculate the ovarian volume and the Antral follicular count by an ultrasonographic method.
MATERIALS AND METHODS: Thirty fertile and thirty sub fertile women whose ages ranged from 26-33yrs were included as group 1 and group 2 respectively. The hormones like AMH ,FSH and oestradiol were assayed. Measurement of the ovarian volume and the antral follicular count by doing a transvaginal ultrasonogram, was done in all the subjects who were involved in both the groups. The correlation test was studied between the variables and the test of significance of the variables between the 2 groups was also analyzed by the Statistical Package Of Social Sciences (SPSS).
RESULTS: The Antral Follicular Count (AFC) and the ovarian volume were negatively correlated with the age. The ovarian volume was positively correlated with the AFC. The FSH negatively correlated with the AFC. The Anti Mullerian Hormone negatively correlated with the age, and it positively correlated with the AFC. The mean values of AFC, FSH, and AMH were also statistically significant between the two groups.
CONCLUSION: AMH can be considered as a marker for assessing the ovarian reserve, as it is cycle independent as compared to the other hormones. The women in the subfertile group with low levels of AMH should be insisted to proceed for ART as early as possible.

Entities:  

Keywords:  AFC; AMH; Ovarian reserve

Year:  2012        PMID: 23373017      PMCID: PMC3552193          DOI: 10.7860/JCDR/2012/5101.2624

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

Review 1.  Strategies for ascertaining ovarian reserve among women suspected of subfertility.

Authors:  M Perloe; D P Levy; E S Sills
Journal:  Int J Fertil Womens Med       Date:  2000 May-Jun

Review 2.  Ovarian reserve testing and the use of prognostic models in patients with subfertility.

Authors:  A Bukman; M J Heineman
Journal:  Hum Reprod Update       Date:  2001 Nov-Dec       Impact factor: 15.610

3.  Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.

Authors:  I A J van Rooij; F J M Broekmans; E R te Velde; B C J M Fauser; L F J M M Bancsi; F H de Jong; A P N Themmen
Journal:  Hum Reprod       Date:  2002-12       Impact factor: 6.918

Review 4.  The variability of female reproductive ageing.

Authors:  Egbert R te Velde; Peter L Pearson
Journal:  Hum Reprod Update       Date:  2002 Mar-Apr       Impact factor: 15.610

5.  Antimüllerian hormone serum levels: a putative marker for ovarian aging.

Authors:  Annemarie de Vet; Joop S E Laven; Frank H de Jong; Axel P N Themmen; Bart C J M Fauser
Journal:  Fertil Steril       Date:  2002-02       Impact factor: 7.329

6.  Serum müllerian-inhibiting substance levels during normal menstrual cycles.

Authors:  C L Cook; Y Siow; S Taylor; M E Fallat
Journal:  Fertil Steril       Date:  2000-04       Impact factor: 7.329

7.  Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles.

Authors:  J L Frattarelli; D F Lauria-Costab; B T Miller; P A Bergh; R T Scott
Journal:  Fertil Steril       Date:  2000-09       Impact factor: 7.329

8.  Age-related changes in ovarian volume, antral follicle counts and basal follicle stimulating hormone levels: comparison between fertile and infertile women.

Authors:  M Erdem; A Erdem; K Biberoglu; M Arslan
Journal:  Gynecol Endocrinol       Date:  2003-06       Impact factor: 2.260

9.  Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception.

Authors:  Scott M Nelson; Robin W Yates; Helen Lyall; Maybeth Jamieson; Isabel Traynor; Marco Gaudoin; Paul Mitchell; Pat Ambrose; Richard Fleming
Journal:  Hum Reprod       Date:  2009-01-10       Impact factor: 6.918

10.  Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility.

Authors:  Annemarie G M G J Mulders; Joop S E Laven; Marinus J C Eijkemans; Frank H de Jong; Axel P N Themmen; Bart C J M Fauser
Journal:  Hum Reprod       Date:  2004-06-24       Impact factor: 6.918

View more
  7 in total

1.  Ovarian reserve in an Egyptian cohort with end-stage kidney disease on hemodialysis and after successful kidney transplantation: a prospective study.

Authors:  Ahmed Fayed; Ahmed Soliman; Mervat Naguib; Mahmoud Soliman; M Salaheldin
Journal:  Int Urol Nephrol       Date:  2019-02-08       Impact factor: 2.370

2.  Perinatal BPA exposure and reproductive axis function in CD-1 mice.

Authors:  Nicole Acevedo; Beverly S Rubin; Cheryl M Schaeberle; Ana M Soto
Journal:  Reprod Toxicol       Date:  2018-05-09       Impact factor: 3.143

3.  Follicle Stimulating Hormone and Anti-Müllerian Hormone among Fertile and Infertile Women in Ile-Ife, Nigeria: Is there A Difference?

Authors:  Temitope Okunola; Kayode Olusegun Ajenifuja; Olabisi Morebise Loto; Afolabi Salawu; Stephen Oluseyi Omitinde
Journal:  Int J Fertil Steril       Date:  2016-11-11

4.  Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone.

Authors:  Zehra Jamil; Syeda Sadia Fatima; Zahra Cheema; Safia Baig; Roha Ahmed Choudhary
Journal:  J Res Med Sci       Date:  2016-11-02       Impact factor: 1.852

5.  Ovarian reserve in nigerian women with sickle cell anaemia: a cross- sectional study.

Authors:  Sunusi Rimi Garba; Christian Chigozie Makwe; Vincent Oluseye Osunkalu; Olufunto Olufela Kalejaiye; Adaiah Priscillia Soibi-Harry; Amina Umar Aliyu; Bosede Bukola Afolabi
Journal:  J Ovarian Res       Date:  2021-12-11       Impact factor: 4.234

6.  Decreasing quality of the new generations of anti-Müllerian hormone assays.

Authors:  Krzysztof Lukaszuk; Beata Ludwikowska; Joanna Liss; Michal Kunicki; Miroslaw Sawczak; Aron Lukaszuk; Lukasz Plociennik; Grzegorz Jakiel; Tomasz Wasniewski; Izabela Woclawek-Potocka; Dorota Bialobrzeska
Journal:  Biomed Res Int       Date:  2014-03-11       Impact factor: 3.411

7.  Mutational Analysis of the Putative Anti-Müllerian Hormone (AMH) Binding Interface on its Type II Receptor, AMHR2.

Authors:  Kaitlin N Hart; David Pépin; Magdalena Czepnik; Patricia K Donahoe; Thomas B Thompson
Journal:  Endocrinology       Date:  2020-07-01       Impact factor: 4.736

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.